Valion Bio (VBIO) Goodwill & Intangibles (2025 - 2026)

Valion Bio (VBIO) posted quarterly Goodwill & Intangibles of $5.7 million for Q4 2025, up 154.12% quarter-over-quarter from $2.2 million in Q3 2025.

Valion Bio (VBIO) Goodwill & Intangibles (2025 - 2026) Analysis & Trends

Valion Bio's Goodwill & Intangibles history runs 1 years deep, the most recent figure standing at $5.7 million for Q4 2025.

In Q4 2025, Goodwill & Intangibles changed N/A year-over-year to $5.7 million; the TTM figure through Dec 2025 stood at $5.7 million (changed N/A YoY), while the FY2025 annual figure was $5.7 million, changed N/A from the prior year.
Goodwill & Intangibles for Q4 2025 stood at $5.7 million, up from $2.2 million in the prior quarter.
The five-year high for Goodwill & Intangibles was $5.7 million in Q4 2025, with the low at $2.2 million in Q3 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Vertex Pharmaceuticals	139.13 Bn	131.28 Bn	2.84 Bn
2	Regeneron Pharmaceuticals	85.77 Bn	77.77 Bn	3.93 Bn
3	Argenx Se	64.64 Bn	59.46 Bn	1.37 Bn
4	Moderna	58.29 Bn	53.16 Bn	52.00 Mn
5	BeOne Medicines	41.92 Bn	36.82 Bn	1.53 Bn
6	Alnylam Pharmaceuticals	31.58 Bn	28.28 Bn	992.69 Mn
7	BioNTech SE	28.12 Bn	9.73 Bn	668.28 Mn
8	Insmed	27.39 Bn	26.22 Bn	358.27 Mn
9	Royalty Pharma	27.27 Bn	26.43 Bn	-
10	Valion Bio	405,599.63	-1.79 Mn	-45,000.00

Download Data